Hemostatic Disorders in Type 1 Diabetes Mellitus

被引:34
作者
Targher, Giovanni [1 ]
Chonchol, Michel [2 ]
Zoppini, Giacomo [1 ]
Franchini, Massimo [3 ]
机构
[1] Univ Verona, Dept Med, Endocrinol Sect, I-37126 Verona, Italy
[2] Univ Colorado, Denver Hlth Sci Ctr, Div Renal Dis & Hypertens, Aurora, CO USA
[3] Univ Hosp Parma, Immunohematol & Transfus Ctr, Dept Pathol & Lab Med, Parma, Italy
关键词
Type; 1; diabetes; coagulation; fibrinolysis; hemostatic disorders; ACTIVATABLE FIBRINOLYSIS INHIBITOR; SOLUBLE CD40 LIGAND; ENDOTHELIAL DYSFUNCTION; MICROVASCULAR COMPLICATIONS; ADHESION MOLECULES; MARKERS; INFLAMMATION; ASSOCIATION; NEPHROPATHY; COAGULATION;
D O I
10.1055/s-0030-1270072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review summarizes current knowledge of the adverse effects of type 1 diabetes mellitus on coagulation and fibrinolysis. Although further larger studies are needed to provide more definitive information, patients with type 1 diabetes exhibit a proinflammatory/procoagulant condition deriving from increased platelet adhesiveness, activation of the coagulation system, and decreased plasma fibrinolytic potential. This review also focuses on recent data from large prospective studies suggesting a strong association between procoagulant imbalance and development of chronic vascular complications in people with type 1 diabetes. It is likely that a greater appreciation of the intimate interactions between endothelial integrity, coagulation and fibrinolytic factors, and platelets in type 1 diabetes will provide a greater understanding of the risk of developing cardiovascular disease and microvascular complications such as nephropathy and retinopathy in this patient population.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 44 条
[41]   Nonalcoholic Fatty Liver Disease as a Contributor to Hypercoagulation and Thrombophilia in the Metabolic Syndrome [J].
Targher, Giovanni ;
Chonchol, Michel ;
Miele, Luca ;
Zoppini, Giacomo ;
Pichiri, Isabella ;
Muggeo, Michele .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (03) :277-287
[42]   Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients -: A novel target of thiazolidinediones [J].
Varo, N ;
Vicent, D ;
Libby, P ;
Nuzzo, R ;
Calle-Pascual, AL ;
Bernal, MR ;
Fernández-Cruz, A ;
Veves, A ;
Jarolim, P ;
Varo, JJ ;
Goldfine, A ;
Horton, E ;
Schönbeck, U .
CIRCULATION, 2003, 107 (21) :2664-2669
[43]   Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy:: evidence for platelet hyperactivity and chronic inflammation [J].
Yngen, M ;
Östenson, CG ;
Hu, H ;
Li, N ;
Hjemdahl, P ;
Wallén, NH .
DIABETOLOGIA, 2004, 47 (03) :537-540
[44]   Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients [J].
Zoppini, G ;
Targher, G ;
Cacciatori, V ;
Guerriero, A ;
Muggeo, M .
DIABETES CARE, 1999, 22 (11) :1871-1874